首页> 外国专利> Use of indole-3-carboxylic acid esters for the inhibition of microsomal prostaglandin E2 synthase

Use of indole-3-carboxylic acid esters for the inhibition of microsomal prostaglandin E2 synthase

机译:吲哚-3-羧酸酯在抑制微粒体前列腺素E2合酶中的用途

摘要

The present invention relates to the use of indole-3-carboxylic acid esters and their derivatives for the inhibition of inducible microsomal prostaglandin E2 synthase-1 and / or for the inhibition of 5-lipoxygenase. In particular, the invention relates to the use of derivatives of 3-carboxy-aryl [g] indole, especially of 2-aryl and 2-arylalkyl-aryl [g] indole-3-carboxylic acid esters and their structural derivatives for the inhibition of inducible microsomal prostaglandin E2 synthase-1 and / or for the inhibition of 5-lipoxygenase. The invention further relates to the use of indole-3-carboxylic acid esters for the preparation of a medicament for the treatment of PGE2- and / or 5-LO-mediated diseases and pathological conditions, in particular of inflammatory chronic inflammations such as rheumatoid arthritis, osteoarthritis, diseases of the cardiovascular system, Asthma, allergic rhinitis, multiple sclerosis, inflammatory skin diseases, osteoporosis and cancer, pain and fever in which PGE2 and / or 5-LO products play a role.
机译:本发明涉及吲哚-3-羧酸酯及其衍生物在抑制可诱导的微粒体前列腺素E 2合酶-1和/或抑制5-脂氧合酶中的用途。特别地,本发明涉及3-羧基-芳基[g]吲哚的衍生物,特别是2-芳基和2-芳基烷基-芳基[g]吲哚-3-羧酸酯的衍生物及其结构衍生物在抑制中的用途。诱导性微粒体前列腺素E2合酶-1和/或用于抑制5-脂氧合酶。本发明进一步涉及吲哚-3-羧酸酯在制备药物中的用途,所述药物用于治疗PGE 2和/或5-LO介导的疾病和病理状况,特别是炎性慢性炎症例如类风湿性关节炎,PGE2和/或5-LO产物在其中起作用的疾病包括:骨关节炎,心血管疾病,哮喘,过敏性鼻炎,多发性硬化症,炎症性皮肤病,骨质疏松症和癌症,疼痛和发烧。

著录项

  • 公开/公告号DE102008027331A1

    专利类型

  • 公开/公告日2009-12-10

    原文格式PDF

  • 申请/专利号DE20081027331

  • 发明设计人

    申请日2008-06-07

  • 分类号A61K31/407;A61K31/405;A61P29;A61P11/06;A61P11/02;A61P25/28;A61P17;A61P3/14;A61P35;

  • 国家 DE

  • 入库时间 2022-08-21 18:28:58

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号